Daxas Approved In EU With Narrow Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
Nycomed's drug gets the green light to treat severe COPD with chronic bronchitis in adult patients with a history of frequent exacerbations, as an add-on to bronchodilator treatment.